Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure
about
A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cellsA successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib.Targeted therapy in rare cancers--adopting the orphans.
P2860
Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Outcome of treatment of chroni ...... ibitors after imatinib failure
@ast
Outcome of treatment of chroni ...... ibitors after imatinib failure
@en
type
label
Outcome of treatment of chroni ...... ibitors after imatinib failure
@ast
Outcome of treatment of chroni ...... ibitors after imatinib failure
@en
prefLabel
Outcome of treatment of chroni ...... ibitors after imatinib failure
@ast
Outcome of treatment of chroni ...... ibitors after imatinib failure
@en
P2860
P50
P1476
Outcome of treatment of chroni ...... ibitors after imatinib failure
@en
P2093
A Megan Cornelison
P2860
P304
P356
10.1016/J.CLML.2011.02.009
P407
P478
11 Suppl 1
P577
2011-04-28T00:00:00Z